Evidence map›Paper›PMID 42131021›Full record

ArticleJournal of orthopaedic case reports2026

Idiopathic Congenital Dislocation of the Knee: Case Series of Spontaneous Reduction.

Nabil Alassaf

Abstract read
In one paragraph

Article in Journal of orthopaedic case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Nabil AlassafDepartment of Orthopedic Surgery, Hail Health Cluster, Hail, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Idiopathic congenital dislocation of the knee (CDK) represents a distinct clinical category. Grade III CDK, defined as knee flexion <30° has a poor prognosis. The standard of care is "as soon as possible" manipulation and casting. Waiting for spontaneous reduction is not regarded as an accepted treatment strategy. The purpose of this study is to report on the occurrence of spontaneous reduction in idiopathic grade III CDK. Materials and Methods: This prospective cohort study included consecutive cases of idiopathic CDK treated from April 2020 to August 2025. Inclusion criteria were: Absence of neuromuscular or genetic diseases, diagnosis of grade III CDK, and follow-up until full recovery. Results: Seven knees in five female patients with grade III CDK were included; two had bilateral CDK. All pregnancies were full-term with cephalic presentation; one infant was delivered by cesarean section. Four neonates were firstborn. Hip ultrasound showed dysplasia in three patients, bilateral in two, and unilateral in one. Spontaneous full reduction occurred in six out of seven knees before 1 month of age. In the remaining knee, the flexion gradually improved to 30°, after which reduction was prompted by casting once for 2 weeks at 11 weeks of age. All knees regained a normal, stable range of motion. Bilateral dysplastic hips normalized spontaneously in one patient, while the other two required fewer than 6 weeks of splinting. Conclusion: These findings suggest a potential role for observation in the management of idiopathic grade III CDK. In this cohort, all infants were non-breech, had no foot deformities, or teratologic etiology. Significance of study: A period of observation is warranted for idiopathic CDK. In this series, six out of seven knees reduced spontaneously, and the remaining knee required only a brief period of casting at approximately 3 months of age.

Indexed as

childrenCongenital knee dislocationhip dysplasiaidiopathic congenital dislocation of the kneeinfantpediatric orthopedicstreatment

Identifiers

PMID42131021
PMCPMC13161960

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.